K.  Kashinath, Vasudevan, N., and D. Reddy, S., ?Studies toward the synthesis of potent anti-inflammatory peptides solomonamides A and B: synthesis of a macrocyclic skeleton and key fragment 4-amino-6-(2 `-amino-4 `-hydroxyphenyl)-3-hydroxy-2-methyl-6-oxohexanoic acid (AHMOA)?, Organic Letters, vol. 14, no. 24, pp. 6222-6225, 2012.

N.  Vasudevan, Kashinath, K., and D. Reddy, S., ?Total synthesis of deoxy-solomonamide B by mimicking biogenesis?, Organic Letters, vol. 16, no. 23, pp. 6148-6151, 2014.

N.  Vasudevan, Jachak, G. R., and D. Reddy, S., ?Breaking and making of rings: a method for the preparation of 4-quinolone-3-carboxylic acid amides and the expensive drug ivacaftor?, European Journal of Organic Chemistry, no. 34, pp. 7433-7437, 2015.

R.  Thakare, Das, S., Vasudevan, N., Jachak, G. R., Reddy, D. S., Dasgupta, A., and Chopra, S., ?Repurposing Ivacaftor for treatment of staphylococcus aureus infections?, International Journal of Antimicrobial Agents, vol. 50, no. 3, pp. 389-392, 2017.

N.  Vasudevan, Sharma, M. K., D. Reddy, S., and Kulkarni, A. A., ?Multi-step continuous flow synthesis of the cystic fibrosis medicine ivacaftor?, Reaction Chemistry & Engineering, vol. 3, no. 4, pp. 520-526, 2018.

N.  Vasudevan, Routholla, G., Illa, G. Teja, and D. Reddy, S., ?Synthesis of alpha-ketoamides using potassium superoxide (KO2) as an oxidizing agent?, Tetrahedron, vol. 76, no. 25, p. 131262, 2020.

G. R.  Jachak, Kashinath, K., Vasudevan, N., Athawale, P. R., Choudhury, R., Dange, S. S., Agarwal, H., Barthwal, M. Kumar, and D. Reddy, S., ?Comprehensive study on solomonamides: total synthesis, stereochemical revision, and SAR studies toward identification of simplified lead?, Journal of Organic Chemistry, vol. 88, no. 24, pp. 17088-17133, 2023.

N.  Vasudevan, Motiwala, Z., Ramesh, R., Wagh, S. B., Shingare, R. D., Katte, R., Anand, A., Choudhary, S., Kumar, A., Gokhale, R. S., Kulkarni, K. A., and D. Reddy, S., ?Synthesis, biological evaluation and docking studies of silicon incorporated diarylpyrroles as MmpL3 inhibitors: an effective strategy towards development of potent anti-tubercular agents?, European Journal of Medicinal Chemistry, vol. 259, p. 115633, 2023.